Target intelligence / Profile preview

High mobility group box 1 pseudogene 51 (HMGB1P51)

Target
HMGB1P51
Molecular classification
Pseudogene
01

Overview

High mobility group box 1 pseudogene 51 (HMGB1P51) is one of many non-protein-coding pseudogenes present in the human genome[1][6]. Pseudogenes such as HMGB1P51 arise from gene duplication or retrotransposition events and generally lack protein-coding potential due to mutations or deletions. While some pseudogenes in other gene families have regulatory roles in gene expression, there is no direct evidence or experimental characterization indicating a functional or therapeutic relevance for HMGB1P51. No disease associations, drug interactions, or biomarker roles have been described for this locus. HMGB1P51 is not a recognized target for drug discovery or therapy, and is not classified as a receptor, enzyme, transporter, or other canonical target class[1][6]. Key points: - HMGB1P51 is a pseudogene, not a functional protein-coding gene[1][6]. - There is no evidence for a therapeutic or biological target role for this entry. - There are no known drugs, biomarkers, or direct disease links associated with HMGB1P51 as of current publicly available data. If your interest is in the protein-coding gene high mobility group box 1 (HMGB1, not HMGB1P51), that gene has well-established biological and disease relevance, but HMGB1P51 does not[1][6].

Other names
HMGB1P51high mobility group box 1 pseudogene 51
02

Biological functions

None experimentally validated for this specific pseudogene[1][6]General pseudogenes may regulate expression of homologous coding genes through mechanisms such as acting as competing endogenous RNAs (ceRNAs) or producing regulatory RNA fragments, but this is not established for HMGB1P51 specifically[2][4]
03

Disease associations

None directly established for HMGB1P51

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 51 (HMGB1P51).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 51 (HMGB1P51).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call